Quantum imaging medical device market seen topping $3.7 billion by 2030

The Business Research Company says the quantum imaging medical device market will rise from $1.41 billion in 2025 to $1.72 billion in 2026, then reach $3.7 billion by 2030. North America led the market in 2025, while Asia-Pacific is expected to grow fastest as demand builds for earlier, more precise diagnosis.

Why it matters: - Quantum imaging medical devices promise sharper diagnostics at a time when providers want earlier disease detection and more precise treatment decisions. - The market's projected growth signals rising investment in advanced imaging, precision medicine and quantum-based tools. - The forecast also points to a broader shift away from older imaging methods that have struggled with accuracy and resolution.

What happened: - The Business Research Company published a quantum imaging medical device market intelligence report covering trends, segments and regional growth. - The report estimates the market will grow from $1.41 billion in 2025 to $1.72 billion in 2026, a 21.4% CAGR. - The report projects the market will reach $3.7 billion by 2030, at a 21.1% CAGR. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Quantum imaging medical devices use quantum physics to produce highly detailed medical images. - The devices analyze interactions at the quantum level to improve visualization of biological structures. - The technology is designed to increase accuracy and resolution while reducing errors and image distortion. - Growth in the market has been supported by weaknesses in traditional imaging techniques, rising cancer diagnosis rates, higher demand for advanced diagnostics, more investment in medical imaging and active academic research in quantum technologies. - The report says future demand will be driven by commercialization of quantum diagnostic tools, AI-based imaging software, expansion in precision medicine, stronger demand for early disease detection and growth in research hospitals. - The report highlights ultra-high resolution imaging, quantum sensor-based diagnostics, precision oncology imaging, low-dose advanced imaging and next-generation visualization technologies as key trends. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company says its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The report offers a free sample and the full market report.

Between the lines: - The biggest near-term opportunity appears to be the overlap between quantum imaging and precision medicine, especially in oncology and early detection. - Personalized healthcare is becoming a clearer demand driver as payers, providers and researchers push for treatments matched to patient-specific needs. - The report cites a February 2024 Personalized Medicine Coalition update showing the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. - That increase suggests the clinical market is moving toward more targeted care, which could raise demand for imaging tools that support individualized diagnosis and treatment planning. - Regional growth patterns imply North America remains the current center of gravity, but Asia-Pacific may become the fastest-expanding market as adoption broadens.

What's next: - The report expects continued commercialization of quantum diagnostic tools and more integration of AI-driven imaging software. - Growth in research hospitals and precision medicine programs is likely to keep supporting market expansion through 2030. - Vendors will likely compete on resolution, dose reduction, visualization quality and sensor-driven performance as the technology matures.